Uric acid and Multiple Sclerosis;Schützt harnsäure vor Multipler Sklerose?

Therapeutische Umschau

Volumn 61, Issue 9, 2004, Pages 553-555

  Mattle, Heinrich P ^a   Lienert, C ^a   Greeve, I ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INOSINE; NITRIC OXIDE; PEROXYNITRITE; URIC ACID;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLOOD BRAIN BARRIER; CHRONIC INFLAMMATION; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE COURSE; GLIA CELL; GOUT; MONOCYTE; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE FIBER; NONHUMAN; PATHOGENESIS; RELAPSE; REMISSION; T LYMPHOCYTE; URIC ACID BLOOD LEVEL;

BIOLOGICAL MARKERS; FREE RADICAL SCAVENGERS; HUMANS; INOSINE; MULTIPLE SCLEROSIS; REFERENCE VALUES; URIC ACID;

EID: 4544300077     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.61.9.553     Document Type: Conference Paper

References (10)

1. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I. Uric acid, a natural scavenger of peroxynitrite, in experimental encephalomyelitis and multiple sclerosis. Proc. Natl Acad Sci 1998; 95: 675-680.
2. Hooper DC, Ohnishi TS, Kean R, Numagami Y, Dietzschold B, Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci 1995; 92: 5312.
3. Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxinitrite: Implications for the treatment of multiple sclerosis. Proc Natl Acad Sci 1997; 94: 2528-2533.
4. Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. PNAS 2002; 99: 16303-16308.
5. Toncev G, Milicic B, Toncev S, Samardzic G. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. European J Neurol 2002; 9: 221-226.
6. Drulovic J, Dujmovic I, Stojsavljevic N, Mesaros S, Andjelkovic S, Miljkovic D, Peric V, Dragutinovic G, Marinkovic J, Levic Z, Stojkovic MM. Uric acid levels in sera from patients with multiple sclerosis. J Neurol 2001; 248: 121-126.
7. Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Fois ML, Arru G, Rosati G. Serum uric acid and multiple sclerosis. Neurol Sci 2002; 23: 183-188.
8. Koprowski H, Spitson SV, Hooper DC. Prospects for the treatment of multiple Sclerosis by raising serum levels of uric acid, a scavenger of peroxinitrite. Ann Neurol 2001; 49: 139.
9. Toncev G, Milicic B, Toncev S, Samardzic G. High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels. Clin Chem Lab Med 2002; 40: 505-508.
10. Constantinescu CS, Freitag P, Kappos L. Increase of serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis. Mult Scler 2000; 6: 378-381.